GovChime
Notice ID: e8aab392ee6341f79c6c3f18b8895a2dSources Sought

Request for Information - Chemistry Analyzers Supplies - Naval Hospital Sigonella

Archived on July 20, 2026. Original response deadline: . Full description on SAM.gov.

Description

This is a Request for Information (RFI) to identify potential sources possessing the capabilities described herein and ascertain whether the required supplies are commercial in nature. This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. In keeping with the standards of FAR Part 10, the Government may request additional information from responders. Responders are solely responsible for all expenses associated with responding to this RFI or any follow-up information request. All information received in response to this RFI or any follow-up information request that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future request for proposal will not be entertained.

NOTE: At this time no solicitation exists. Therefore, please do not request a copy of the solicitation. NO PHONE CALLS WILL BE ACCEPTED. It is the responsibility of any potential Offeror to monitor this site for the release of any solicitation.

  1. RFI Title: Indefinite Delivery Indefinite Quantity (IDIQ) supplies for Vitros 7600 chemistry and immunochemistry analyzers for the Defense Health Agency (DHA) Medical Treatment Facility (MTF) in Sicily (Italy).
  2. LOCATION: U.S. NMRTC Sigonella – NAS , Strada Statale 192 KM 15, Catania-Enna, Sigonella, Sicily (Italy)
  3. BACKGROUND: The U.S. Naval Hospital Sigonella Laboratory Department requires an IDIQ contract to provide materials necessary for two Vitros 7600 chemistry and immunochemistry analyzers.  These supplies are used to perform critical care testing including cardiac markers, liver enzymes, kidney function and BHCG testing needed for emergent patient care and essential to hospital operation. Given the critical nature of the testing performed and that the products required strict temperature control, supplies must be delivered within four (4) days of order placement and must be received at necessary temperatures listed within the Statement of Work. (SOW)
  4. DESCRIPTION: NAICS 334516 - Analytical Laboratory Instrument Manufacturing, PSC 6550 - In vitro diagnostic substances, reagents, test kits and sets. See DRAFT Statement of Work (SOW).

RFI SUBMISSION INSTRUCTIONS:

Responses to the RFI shall adhere to the following formatting and outline instructions:

  1. All submissions shall be made electronically and be in one of the following formats: Microsoft Word or Adobe PDF.
  2. Cover Page (1 page)

        -              Title

        -              Organization

        -              Responder’s technical and administrative points of contact (names, addresses, phone numbers and email addresses).

        -              CAGE Code

3.     Capabilities statement SHALL address the following:

                -              Contractor’s clear understanding and ability to perform the scope of this requirement as detailed in the DRAFT SOW. Specifically delivery within four days at required temperatures. Provide information on how required temperatures will be maintain during delivery.

                -              Contractor’s experience performing the same or similar work as detailed in the DRAFT SOW.

                -              Existing contract vehicles (e.g., GSA schedule) under which the responder currently offers these services, if any.

                -              Whether the responder provides the required services to the general public under terms and conditions similar to those offered to the Federal Government.

RESPONSES DUE: July 19, 2026 by 5 pm EST

SUBMISSION TO: Ms. Carol Uebelacker, carol.e.uebelacker.civ@health.mil

Full description on SAM.gov

Overview

Agency:
Department of WarDEFENSE HEALTH AGENCY (DHA)
Office:DEFENSE HEALTH AGENCY
Posted:July 4, 2026
NAICS:325413: In-Vitro Diagnostic Substance Manufacturing
Last Updated:Aug 21, 2026
PSC:6550: IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Set-Aside:Not specified
Type:Sources Sought
Place of Performance:Sicily, Catania

Award Overview

Possible prior contracts

Sign in to see possible prior contracts for this requirement (matched by agency, NAICS and place of performance; not confirmed).

Contacts

Contracting Officer

Primary Contact

Documents

Showing 1 of 1 items

Document
Source
Agency
Posted Date
File Size
Actions
Sources SoughtDEFENSE HEALTH AGENCY (DHA)Jul 4, 202681.25 KB

Lifecycle

Solicitation:044549
  1. Market Research

Pre-solicitation or formal solicitation typically follows within 30–180 days. (estimate)

  1. Market ResearchCurrentJul 4, 2026

    Request for Information - Chemistry Analyzers Supplies - Naval Hospital Sigonella

    Notice e8aab392ee6341f79c6c3f18b8895a2d on SAM.gov

Similar Opportunities

Title
Phase
Agency
NAICS
Set Aside
Posted
Deadline
Location

Additional Details

Solicitation Number

044549

Archive Date

Jul 20, 2026

Place of Performance Country

ITALY

Office Address

FREDERICK, MD, 21702